Home > Products > Novel inhibitors
Cat. No. Product name CAS No.
DCC1720 Ddr-trk-1n

Negative control for DDR-TRK-1

DCC1721 Dea Nonoate Sodium Salt

NO donor, generating a controlled release of nitric oxide in solution.

138475-09-9
DCC1722 Deacm-caged D-luciferin

Coumarin-caged D-luciferin, being excited in the caged group only by light of wavelength ranging within 400-430 nm

DCC1723 Deac-pda-atp

Fluorophore to myosin or actomyosin

807621-54-1
DCC1724 Debio-1452-nh3

Novel potent inhibitor of the enoyl-acyl carrier protein reductase FabI, reducing bacterial burden in mice and rescuing mice from lethal infections with clinical isolates of Acinetobacter baumannii, Klebsiella pneumoniae and E. coli

DCC1725 Deferasirox Ferrate(iii) Tripotassium Complex

Deferasirox iron complex

554445-58-8
DCC1726 Deferoxamine Hydrochloride

Iron chelating agent, chelating iron from intra-lysosomal ferritin and hemosiderin forming ferrioxamine, a water-soluble chelate excreted by the kidneys and in the feces via the bile

1950-39-6
DCC1727 Degrader Bt1

Novel selective degrader of BCR-ABL over c-ABL in leukemia cancer cells

DCC1728 Dehydrorabelomycin

Natural polyketide matabolite

30954-70-2
DCC1729 Delcasertib

Novel selective δ-protein kinase C inhibitor

949100-39-4
DCC1730 Delta-tocopherol

Vitamin E variant, inhibiting prostate adenocarcinoma, lung tumorigenesis, promoting thermogenic gene expression via PGC-1α upregulation, preventing methylglyoxal-induced apoptosis by reducing ROS generation and inhibiting apoptotic signaling cascades

119-13-1
DCC1731 Demethoxyviridin

Potent inhibitor of PI3 kinases

56660-21-0
DCC1732 Denagliptin Tosylate

Selective DPP-IV Inhibitor

811432-66-3
DCC1733 Denaverine Hydrochloride

Antispasmodic agent, improving the elasticity of the soft birth canal and regulating labor contractions

3321-06-0
DCC1734 Denosomin

Novel anti-Alzheimer's disease agent, ameliorates spinal cord injury via axonal growth associated with astrocyte-secreted vimentin

DCC1735 Denv2-in-1

Novel selective inhibitor of the DENV2 protease, inhibiting flavivirus protease through targeted covalent modification of active site serine, contrary to an allosteric binding mechanism as previously described

DCC1736 Denv2-in-2

Novel selective inhibitor of the DENV2 protease, inhibiting flavivirus protease through targeted covalent modification of active site serine, contrary to an allosteric binding mechanism as previously described

DCC1737 Denv2-in-3

Novel selective inhibitor of the DENV2 protease, inhibiting flavivirus protease through targeted covalent modification of active site serine, contrary to an allosteric binding mechanism as previously described

DCC1738 Deox B 7,4

Novel reversible microtubule inhibitor, increasing lysosomal V-ATPase activity and lysosome acidity

674786-37-9
DCC1739 Deoxy-dalsir

Novel selective and sensitive near-infrared fluorescent probe for visualization of endogenous nitric oxide in living cells and animals

DCC1740 Deoxynybomycin

Selective anti-tumor agent, inducing apoptosis and inhibiting topoisomerase I

27259-98-9
DCC1741 Depmpo

Most efficient spin trap for the in vitro and in vivo detection of O-, N-, S- and C-centered free radicals

157230-67-6
Page 1300 / Total 1557 FirstPrevNextLastGoto